CPHI — China Pharma Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $4.48m
- $6.44m
- $7.01m
Annual cashflow statement for China Pharma Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.7 | -2.87 | -3.4 | -3.97 | -3.08 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 17.3 | 0.115 | 0.01 | -0.016 | 0.03 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.11 | 0.03 | 0.052 | 0.878 | -0.404 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0.608 | -0.042 | -0.25 | -0.41 | -0.7 |
| Capital Expenditures | -0.136 | -0.867 | -0.438 | -0.402 | -0.012 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.136 | -0.867 | -0.438 | -0.402 | -0.012 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.73 | 0.624 | 4.6 | -1.77 | 0.073 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.28 | -0.227 | 3.9 | -2.83 | -0.606 |